STEPHANIE KIRWIN: Open Payments
NPI 1043972292 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 7 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $122 |
| Hologic Sales and Service, LLC | 1 | $29 |
| LEO Pharma Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Bioventus LLC | 1 | $16 |
Products named: Yeztugo, APTIMA, ANZUPGO, SHINGRIX, CAPLYTA, AIRSUPRA, EXOGEN ULTRASOUND BONE HEALING SYSTEM.
Industry payments across CA — which companies pay providers there.
